ARCHIVES

Volasertib and LDAC Doubled Response in Older Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984